Volume 8.01 | Jan 14

Cord Blood News 8.01 January 14, 2016
Cord Blood News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  CBN on Twitter
 
TOP STORY
Low Oxygen Tension Modulates the Insulin-Like Growth Factor -1 or -2 Signaling via Both Insulin-like Growth Factor-1 Receptor and Insulin Receptor to Maintain Stem Cell Identity in Placental Mesenchymal Stem Cells
Scientists hypothesized that insulin like growth factors (IGF)-1 and IGF-2 signal via distinct signaling pathways under low oxygen tension to maintain placental mesenchymal stem cells multipotency. [Endocrinology]
Abstract | Full Article
Get More of the Cells You Need with StemSpan™ CD34+ Cell Expansion Supplement and StemSpan™ SFEM
 
PUBLICATIONS (Ranked by impact factor of the journal)
Endothelium-Targeted Human Delta-Like 1 Enhances the Regeneration and Homing of Human Cord Blood Stem and Progenitor Cells
Investigators produced an endothelium-targeted soluble Notch ligand, the delta-serrate-lag-2 domain of human delta-like 1 fused with a RGD motif, and tested the effects of this protein on human umbilical cord blood hematopoietic stem and progenitor cells ex vivo and in vivo. [J Transl Med] Abstract

Adverse Reactions during Stem Cell Infusion in Children Treated with Autologous and Allogeneic Stem Cell Transplantation
Researchers retrospectively studied pediatric patients undergoing autologous and allogeneic hematopoietic stem cell transplantation to determine the incidence and grade of adverse reactions during stem cell infusion and their predictors. [Bone Marrow Transplant] Abstract

In Vitro and In Vivo Evaluation of Cord Blood Hematopoietic Stem and Progenitor Cells Amplified with Glycosaminoglycan Mimetic
Umbilical cord blood CD34+ cells were expanded with serum-free medium, SCF, TPO, FLT3-lig and G-CSF during 12 days in the absence or the presence of increasing OTR4131 concentrations. Proliferation ratio, cell viability and phenotype, functional assays, migration capacity and NOD-scid/γc-/- mice engraftment were assessed after expansion. [Stem Cell Res Ther] Full Article

Biological Impact of Xeno-Free Chemically Defined Cryopreservation Medium on Amniotic Epithelial Cells
Xeno-free cryopreservation of human amnion-derived stem cells was feasible and can be standardized to establish a bio-bank with human amnion-derived stem cells for future clinical application. [Stem Cell Res Ther] Full Article

Stem Cells in Aggregate Form to Enhance Chondrogenesis in Hydrogels
Scientists compared the influence of cell phenotype, aggregate size, and aggregate number on chondrogenic differentiation in a generic hydrogel platform. Despite being differing cell sources, both rat bone marrow-derived mesenchymal stem cell and human umbilical cord Wharton’s jelly cell aggregates were consistent in outperforming cell suspension control groups in biosynthesis and chondrogenesis. [PLoS One] Full Article

The Protective Effect of Human Umbilical Cord Blood CD34+ Cells and Estradiol against Focal Cerebral Ischemia in Female Ovariectomized Rat: Cerebral MR Imaging and Immunohistochemical Study
Scientists investigated whether the protective effect of CD34+ cells against ischemic injury can be reinforced with complemental estradiol treatment in female ovariectomized rat and its possible mechanism. [PLoS One] Full Article

Heat Shock Protein 60 Affects Behavioral Improvement in a Rat Model of Parkinson’s Disease Grafted with Human Umbilical Cord Mesenchymal Stem Cell-Derived Dopaminergic-Like Neurons
Researchers demonstrated that human umbilical cord mesenchymal stem cells (hUC-MSCs)-based cell transplantation is potential therapeutic treatment for Parkinson’s disease (PD), and hUC-MSCs-derived DAergic-like neurons appear to be favorable candidates for cell replacement therapy in PD. [Neurochem Res] Abstract

New Cell Separation Kits to Isolate 90% Pure CD34+ Cells from Cord Blood. See the data and learn more here!
 
REVIEWS
Converting Cell Fates: Generating Hematopoietic Stem Cells De Novo via Transcription Factor Reprogramming
The authors discuss the recent efforts undertaken using transcription factor-based reprogramming strategies to convert several cell types into hematopoietic stem cells. [Ann N Y Acad Sci] Abstract

Visit our reviews page to see a complete list of reviews in the cord blood research field.
 
INDUSTRY NEWS
GE Healthcare, FedDev Ontario Commit CAD $40 Million for New CCRM-Led Centre to Solve Cell Therapy Manufacturing Challenges
GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies in Toronto with an investment of $40 million from GE and FedDev Ontario. [Centre for Commercialization of Regenerative Medicine] Press Release

Quad Technologies Collaborates with University of Massachusetts Medical School to Highlight Benefits of Novel Cell Separation Solution
Quad Technologies has partnered with the University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood. [Quad Technologies] Press Release

U.S. Food & Drug Administration Grants Orphan Drug Designation to Pluristem’s PLX-PAD Cells for Treatment of Severe Preeclampsia
Pluristem Therapeutics Inc. announced that the U.S. Food and Drug Administration has granted the company’s PLX-PAD cells orphan drug designation in the treatment of severe preeclampsia. [Pluristem Therapeutics Inc.] Press Release

From our sponsor: Culturing hematopoietic stem and progenitor cells? Download the technical bulletin.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW 28th European Organization for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR) Symposium
November 29-December 2, 2016
Munich, Germany

Visit our events page to see a complete list of events in the cord blood community.
 
JOB OPPORTUNITIES
NEW PhD Position – Stem Cells and Transplantation (University of Geneva)

Postdoctoral Fellow – Stem Cell Biology (Krembil Research Institute)

Research Specialist – Stem Cells from the Hematopoietic System (Howard Hughes Medical Institute)

Doctoral Fellow – Stem Cell Research (Krembil Research Institute)

Postdoctoral position – Regenerative Medicine (University of Copenhagen)

Stem Cell Scientist and Postdoctoral Positions (National Center for Advancing Translational Science)

Postdoctoral Position – Cell and Molecular Biology of Leukemia (Virginia Commonwealth University)

Postdoctoral Research Scientist – Lymphocyte Trafficking Mechanisms in Allogeneic Stem-Cell Transplantation (Columbia University Medical Center)

Assistant/Associate/Full Member Faculty – Myeloid Malignancies (Fred Hutchinson Cancer Research Center)

Assistant Member – Cord Blood Transplantation (Fred Hutchinson Cancer Research Center)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Cord Blood News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Cord Blood News: Archives | Events | Contact Us